Insider selling at Azenta, even at a lower share price, implies they considered it reasonable. Despite some alignment with common shareholders, the lack of insider buying over the past year is discouraging.
The elevated P/S ratio of Azenta shows the market's faith in its capacity to weather global industry headwinds. This is why Azenta's P/S ratio outpaces most other firms. Shareholder sentiment may remain steady barring any shift in these circumstances.
Azenta stock may not be an optimal investment now considering the negative growth outlook and fair valuation. Its high beta could offer future trades if market conditions change.
The large sales by insiders, even at a price below the current rate, are seen as a potentially discouraging sign. However, insiders owning a reasonable chunk of the company indicates an alignment of interests with other shareholders.
Despite Azenta's falling revenues and non-profitability, the stock has delivered respectable returns. The link between past revenue performance and share price remains murky. A recent uptick in one-year TSR Vs five-year TSR suggests potentially growing business momentum.
Gainers: •$テラバンス・バイオファーマ(TBPH.US)$+15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln) •$Amryt Pharma(AMYT.US)$+11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome) •$グリーンブリック・パートナーズ(GRBK.US)$+7.3% (to join S&P SmallCap 600) •$TransGlobe Energy(TGA.US)$+6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
アゼンタに関するコメント
コラムUS Top Gap Ups and Downs on 8/9: AZTA, TOST, DOCS, RBLX and More
Gap Ups
1. $アゼンタ(AZTA.US)$ - up 14.9%
2. $トースト(TOST.US)$ - up 12.1%
3. $セルシウス・ホールディングス(CELH.US)$ - up 9.6%
4. $アクソン・エンタープライズ(AXON.US)$ - up 9.2%
5. $マルケタ(MQ.US)$ - up 7.6%
6. $アカマイ・テクノロジーズ(AKAM.US)$ - up 6.1%
7. $クーパン(CPNG.US)$ - up 5.8%
8. $ペン・エンターテインメント(PENN.US)$ - up 5.3%
9...
コラムUS Top Gap Ups and Downs on 7/13: JD, DB, PGR, INFY and More
Gap Ups
1. $コリア・エレクトリック・パワー(KEP.US)$ - up 2.9%
2. $ピルグリムズ・プライド(PPC.US)$ - up 2.6%
3. $トレード・デスク(TTD.US)$ - up 2.0%
4. $シバンエ・スティルウォーター(SBSW.US)$ - up 1.9%
5. $リオ・ティント(RIO.US)$ - up 1.8%
6. $インフォシス・テクノロジーズ(INFY.US)$ - up 1.8%
7. $JD.COM(京東商城)(JD.US)$ - up 1.7%
8. $ドイツ銀行(DB.US)$ - up 1.7%...
11/15 Watchlist
コラムToday's pre-market stock movers: TSLA, JPM, NVAX, CAG and more
• $テラバンス・バイオファーマ(TBPH.US)$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma(AMYT.US)$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $グリーンブリック・パートナーズ(GRBK.US)$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy(TGA.US)$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
コラムTop upgrades and downgrades on 3/21
• $エアープロダクツ・アンド・ケミカルズ(APD.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $275
• $アソシエーテッド・バンコープ(ASB.US)$: Wells Fargo Upgrades to Overweight from Equal Weight - PT $28 (from $26)
• $アームストロング・ワールド・インダストリーズ(AWI.US)$: Jefferies Upgrades to Buy from Hold - PT $111 (from $101)
• $ブラックベリー(BB.US)$: RBC Capital Upgrades to Sector Perform from Underperform - PT $7
• $コマース・バンクシェアーズ(CBSH.US)$: Wells Fargo Upgrades to Equal Weight from...
まだコメントはありません